Literature DB >> 16931815

Mathematical model of the first wave of Plasmodium falciparum asexual parasitemia in non-immune and vaccinated individuals.

Klaus Dietz1, Günter Raddatz, Louis Molineaux.   

Abstract

We present a dynamic model of the highly pathogenic first wave of Plasmodium falciparum asexual parasitemia in non-immune persons. The model was successfully fitted to malaria therapy data. This required four case-specific parameters: the basic two-day multiplication factor, the time of onset of adaptive immunity, and the effective dose 50 densities for the innate and adaptive immune responses, respectively. All four parameters show large case-dependent variation that is mainly attributable to host factors. According to the model, the maximum value of the first wave is controlled mainly by the innate immune response. We used the model to explore the expected effects of vaccines targeting the parasite's asexual blood stages on the basis of what we consider to be the biologically most plausible assumptions concerning the parameter modifications induced by vaccination. According to our simulations, the benefit of antiparasitic vaccination is strongly host dependent and vaccine efficacy at low immunogenicity is much larger against severe disease than against fever. This has implications for the early testing of the protective efficacy of a vaccine in humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931815     DOI: 10.4269/ajtmh.2006.75.46

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  31 in total

1.  Modelling heterogeneity and the impact of chemotherapy and vaccination against human hookworm.

Authors:  L Sabatelli; A C Ghani; L C Rodrigues; P J Hotez; S Brooker
Journal:  J R Soc Interface       Date:  2008-11-06       Impact factor: 4.118

2.  Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.

Authors:  K Stepniewska; N J White
Journal:  Antimicrob Agents Chemother       Date:  2008-02-25       Impact factor: 5.191

Review 3.  Making the most of clinical data: reviewing the role of pharmacokinetic-pharmacodynamic models of anti-malarial drugs.

Authors:  Julie A Simpson; Sophie Zaloumis; Alysha M DeLivera; Ric N Price; James M McCaw
Journal:  AAPS J       Date:  2014-07-24       Impact factor: 4.009

Review 4.  Experimental human challenge infections can accelerate clinical malaria vaccine development.

Authors:  Robert W Sauerwein; Meta Roestenberg; Vasee S Moorthy
Journal:  Nat Rev Immunol       Date:  2011-01       Impact factor: 53.106

5.  Partitioning regulatory mechanisms of within-host malaria dynamics using the effective propagation number.

Authors:  C J E Metcalf; A L Graham; S Huijben; V C Barclay; G H Long; B T Grenfell; A F Read; O N Bjørnstad
Journal:  Science       Date:  2011-08-19       Impact factor: 47.728

6.  On the control of acute rodent malaria infections by innate immunity.

Authors:  Beth F Kochin; Andrew J Yates; Jacobus C de Roode; Rustom Antia
Journal:  PLoS One       Date:  2010-05-06       Impact factor: 3.240

7.  Quantitative analysis of immune response and erythropoiesis during rodent malarial infection.

Authors:  Martin R Miller; Lars Råberg; Andrew F Read; Nicholas J Savill
Journal:  PLoS Comput Biol       Date:  2010-09-30       Impact factor: 4.475

8.  The dynamics of acute malaria infections. I. Effect of the parasite's red blood cell preference.

Authors:  Rustom Antia; Andrew Yates; Jacobus C de Roode
Journal:  Proc Biol Sci       Date:  2008-06-22       Impact factor: 5.349

9.  Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance.

Authors:  Nicholas J White; Wirichada Pongtavornpinyo; Richard J Maude; Sompob Saralamba; Ricardo Aguas; Kasia Stepniewska; Sue J Lee; Arjen M Dondorp; Lisa J White; Nicholas P J Day
Journal:  Malar J       Date:  2009-11-11       Impact factor: 2.979

10.  Mechanistic within-host models of the asexual Plasmodium falciparum infection: a review and analytical assessment.

Authors:  Flavia Camponovo; Tamsin E Lee; Jonathan R Russell; Lydia Burgert; Jaline Gerardin; Melissa A Penny
Journal:  Malar J       Date:  2021-07-10       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.